Background Image
Menu

News: 2019

Sight and Sound Technology meet with Microsoft CEO

7 October 2019

Sight and Sound Technology meet with Microsoft CEO

Last week was one of the high points for the Sight and Sound Ireland office, as Business Development Manager Stuart Lawler had the opportunity to meet with Microsoft CEO Satya Nadella, at Microsoft's Dublin offices. Stuart highlighted to Satya the importance of universal design...

Could smart pill bottles dispense a solution to drug non-adherence?

2 October 2019

Could smart pill bottles dispense a solution to drug non-adherence?

Article from Pharmaceutical Technology - 25th September 2019 … To tackle the challenge of medication adherence, particularly in the clinical trial space, UK health tech company Elucid has created a smart pill bottle and mobile app called Pill Connect. Currently in the trial...

AI-driven growth: ‘Sat nav’ for diabetes Gendius has huge ambitions after £500k fundraise

30 September 2019

AI-driven growth: ‘Sat nav’ for diabetes Gendius has huge ambitions after £500k fundraise

AI-driven growth for Gendius after a successful crowdfunding round - good to hear from co-founder Rory Cameron a bout the tech startup's growth ambitions in Tech Nation … Based in Alderley Edge in Cheshire, healthtech startup Gendius has developed an app-based platform to help...

eLucid gets US patents for smart pill dispenser device

26 September 2019

eLucid gets US patents for smart pill dispenser device

Health tech firm eLucid mHealth has been granted a pair of US patents for its recently-launched Pill Connect, a smart device that aims to tackle the problem of non-adherence to medicines. The patents (numbers 9,984,213 and 10,224,116) are the first to be awarded for Manchester...

UP Ventures and Novartis announce Cohort for Greater Manchester Future of Health Challenge

11 September 2019

UP Ventures and Novartis announce Cohort for Greater Manchester Future of Health Challenge

Global tech accelerator, UP Ventures, has announced the 15 businesses who will make up the cohort to take part in the upcoming GM Future of Health Challenge at The Landing in MediaCityUK. Tech investment and accelerator specialists UP Ventures are delivering the programme in...

Rinicare Announces Appointment Of New Chairman

14 August 2019

Rinicare Announces Appointment Of New Chairman

Manchester, UK, 25th July 2019 – Rinicare Limited a leading intelligent healthcare company announced today the appointment of Duane Lawrence as non-executive chairman. Duane has 30 years’ experience of leading healthcare technology businesses across five continents.

Rinicare SAFE: Ground-breaking UHMBT research study has potential to transform care on hospital wards across UK

13 August 2019

Rinicare SAFE: Ground-breaking UHMBT research study has potential to transform care on hospital wards across UK

The Research and Development team at University Hospitals of Morecambe Bay NHS Foundation Trust (UHMBT) is hosting the first UK study of new technology designed to revolutionise care on hospital wards. A new thermal sensor-based alarm system has been developed to enable ward...

Dementia testing specialist boosted with six-figure investment

12 August 2019

Dementia testing specialist boosted with six-figure investment

A fast-growing company that specialises in the genetic testing for Alzheimer’s disease has secured a six figure investment to boost its growth plans. Maven Capital Partners, one of the UK’s most active SME finance providers, has invested an undisclosed sum on behalf...

The smart pill pot tells you (and your doctor) if you miss a dose

12 August 2019

The smart pill pot tells you (and your doctor) if you miss a dose

Lucy Elkins of the Daily Mail writes about Elucid's Pill Connect. https://www.dailymail.co.uk/health/article-7299039/The-smart-pill-pot-tells-doctor-miss-dose.html

The AMR Centre set for partnership with Shionogi for new superbug therapy

23 July 2019

The AMR Centre set for partnership with Shionogi for new superbug therapy

The AMR Centre at Alderley Park has struck a landmark agreement with Japanese pharma company Shionogi. The deal will see the pair take forward the former's anti-virulence program COT-143, with the therapy designed to help the body tackle Pseudomonas aeruginosa infections; a hard...